Research Co-Authored by FHC Europe VP Andrei Barborica

Andrei Barborica, VP of FHC Europe and CTO of FHC, Inc., is the senior author on a study accepted for publication in World Neurosurgery. The article, entitled “Clinical Accuracy of Customized Sterotactic Fixtures for Stero-EEG,” was published online in September 2017.

Stereo-EEG is a diagnostic methodology involving 3D exploration of brain structures using depth electrodes for locating the area of the cerebral cortex responsible for causing seizures in patients with drug-resistant epilepsy. Although a variety of frame-based, frameless, and robotic stereotactic systems are already used for the accurate placement of depth electrodes, researchers involved in this study examined the safety and accuracy of a patient-specific stereotactic platform in a clinical setting. 

Using the FHC microTargeting™ platform as a model, researchers introduce a fully customized design that has all the constructive elements positioned by a computer algorithm, according to the planned trajectories, anchoring points, and anatomical constraints. All the constructive elements form a single-body fixture which allows for the efficient implantation of multiple depth electrodes following trajectories having a wide range of orientations.

 Based on the results of the study, researchers concluded that patient-customized platforms are comparable in terms of safety, accuracy and simplicity of use to the existing robotic devices for implantation of depth electrodes in patients undergoing stereo-EEG investigations.

More information on this paper is available at  Learn more about FHC’s microTargeting platform at


Leave blank for all. Otherwise, the first selected term will be the default instead of "Any".

Browse through FHC’s wide array of neurosurgical research equipment

View Our Products